Therapy of the Alzheimer-dementia - Modern anti-dementia recommended by experts

被引：0

作者：

Oetzel, Stefan

机构：

来源：

NERVENHEILKUNDE | 2007年 / 26卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1051 / 1051

页数：1

共 7 条

[1] Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease [J].

Brodaty, H ;

Corey-Bloom, J ;

Potocnik, FCV ;

Truyen, L ;

Gold, M ;

Damaraju, CRV .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 20 (2-3) :120-132

[2] Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial [J].

Erkinjuntti, T ;

Kurz, A ;

Gauthier, S ;

Bullock, R ;

Lilienfeld, S ;

Damaraju, CV .

LANCET, 2002, 359 (9314) :1283-1290

[3]

Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), 2007, CHOLINESTERASEHEMMER

[4]

MATTHEWS F, MRC REPORT APPENDIX

[5] Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial [J].

Rockwood, K ;

Fay, S ;

Song, XW ;

MacKnight, C ;

Gorman, M .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (08) :1099-1105

[6] The effects of galantamine treatment on caregiver time in Alzheimer's disease [J].

Sano, M ;

Wilcock, GK ;

van Baelen, B ;

Kavanagh, S .

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (10) :942-950

[7] A 5-month, randomized, placebo-controlled trial of galantamine in AD [J].

Tariot, PN ;

Solomon, PR ;

Morris, JC ;

Kershaw, P ;

Lilienfeld, S ;

Ding, C .

NEUROLOGY, 2000, 54 (12) :2269-2276

← 1 →